Manager TitleAgeSince
Chief Executive Officer 49 2025-05-30
Director of Finance/CFO 61 2025-05-30
Sales & Marketing 53 2023-12-31
Director TitleAgeSince
Director/Board Member 62 2019-12-31
Chairman 42 2025-05-31
Director/Board Member 75 2025-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-35.15%-30.97% - - 717K
+1.16%-2.08%-21.33%+0.66% 176B
+2.44%+0.88%-0.25%+13.71% 116B
+0.77%-0.13%+11.28%+83.21% 61.36B
-1.15%-7.08%+5.83%+39.93% 49.42B
+1.26%+0.46%-3.14%-32.01% 48.44B
+1.58%-0.43%+11.37%-17.11% 31.33B
+0.32%-6.14% - - 28.54B
+1.43%+3.91%+36.28%-11.80% 24.37B
+0.73%-6.97%-12.66%+4.70% 21.57B
Average -2.69%-4.92%+3.42%+10.16% 61.98B
Weighted average by Cap. +1.13%-4.84%-3.77%+12.31%
Logo ProstaLund AB
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
Employees
6
  1. Stock Market
  2. Stocks
  3. PLUN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!